Clinical Trials Browser

Advanced Lung Non-Squamous Non-Small Cell Carcinoma × navitoclax × Clear all

NCT02520778 2024-08-21

Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

Phase 1 Completed

Advanced Lung Non-Squamous Non-Small Cell Carcinoma